Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells
- 15 September 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 102 (6) , 1966-1977
- https://doi.org/10.1182/blood-2002-11-3400
Abstract
Stimulation of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) increases the expression of CXCR4 on endothelial cells, rendering these cells more responsive to stromal-derived factor 1 (SDF-1), an angiogenic CXC chemokine and unique ligand for CXCR4. Here, we show that prostaglandin E2 (PGE2) mediates the effects of bFGF and VEGF in up-regulating CXCR4 expression on human microvascular endothelial cells (HMECs). Forskolin or 3-isobutyl-1-methyl xanthine (IBMX), 2 inducers of adenylate cyclase, markedly enhanced, whereas cyclooxygenase (COX) inhibitors including aspirin, piroxicam, and NS398 markedly inhibited CXCR4 expression on HMECs. Furthermore, the ability of PGE2 to augment in vitro tubular formation in SDF-1α containing matrigel was inhibited completely by blocking CXCR4. Treatment of bFGF- or VEGF-stimulated HMECs with COX inhibitors blocked tubular formation by about 50% to 70%. Prostaglandin-induced human endothelial cell organization and subsequent vascularization can be inhibited to a greater extent by a neutralizing antibody to human CXCR4 in severe combined immunodeficient mice. Additionally, VEGF- and bFGF-induced angiogenesis in vivo was also inhibited by about 50% by NS-398 or piroxicam, and this inhibitory effect was accompanied by decreased expression of CXCR4 on murine endothelial cells. Consequently, by inducing CXCR4 expression, prostaglandin accounts for about 50% of the tubular formation in vitro and in vivo angiogenic effects of VEGF and bFGF. Moreover, augmentation of CXCR4 expression by VEGF, bFGF, and PGE2 involves stimulation of transcription factors binding to the Sp1-binding sites within the promoter region of the CXCR4 gene. These findings indicate that PGE2 is a mediator of VEGF- and bFGF-induced CXCR4-dependent neovessel assembly in vivo and show that angiogenic effects of PGE2 require CXCR4 expression.Keywords
This publication has 72 references indexed in Scilit:
- Vascular endothelial growth factor-induced prostacyclin production is mediated by a protein kinase C (PKC)-dependent activation of extracellular signal-regulated protein kinases 1 and 2 involving PKC-δ and by mobilization of intracellular Ca2+Biochemical Journal, 2001
- The Phosphodiesterase Inhibitor IBMX Suppresses TNF-α Expression in Human Adipocyte Precursor Cells: A Possible Explanation for its Adipogenic EffectHormone and Metabolic Research, 1999
- Basic Fibroblast Growth Factor Induces Cyclooxygenase-2 Expression in Endothelial Cells Derived from BoneBiochemical and Biophysical Research Communications, 1999
- The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tractNature, 1998
- Compensatory Prostaglandin E2 Biosynthesis in Cyclooxygenase 1 or 2 Null CellsThe Journal of Experimental Medicine, 1998
- Chemokine Receptor CXCR4 Expression in EndotheliumBiochemical and Biophysical Research Communications, 1998
- Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase IINature, 1995
- EGF and PGE2: Effects on corneal endothelial cell migration and monolayer spreading during wound repairin vitroCurrent Eye Research, 1995
- Acidic and Basic Fibroblast Growth Factors have Comparable Effects on the Haemostatic Function of Vascular EndotheliumGrowth Factors, 1995
- Leukotriene C4 stimulates angiogenesis in bovine carotid artery endothelial cells in vitroBiochemical and Biophysical Research Communications, 1989